Results 141 to 150 of about 1,093,239 (312)

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source

ON THE ASSESSMENT OF THE LEFT VENTRICLULAR MYOCARDIAL PERFUSION IN MYOCARDIAL INFARCTION USING SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY

Неотложная медицинская помощь, 2016
SUMMARY. On the basis of single photon emission computed tomography of the myocardium (SPECT) with Technetril 99mTc performed in 81 patients with myocardial infarction (MI), we confirmed the proportion of myocardial segments of the left ventricle (LV ...
G. A. Gazaryan, V. A. Ryabinin, E. V. Migunova, N. A. Barkalaya, N. E. Kudryashova, A. P. Golikov   +5 more
doaj  

Nitroglycerine-Responsive Ischemic Trigeminal Premature Ventricular Contractions in Stented Myocardial Infarction with Hypertensive Crises and Transient Ischemic Attack [PDF]

, 2021
Yasser Mohammed Hassanain Elsayed
openalex   +1 more source

An open‐label, single‐arm, dose‐escalating concentration–QT study to investigate the cardiac effects and safety of paroxetine in healthy adults

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Paroxetine is a selective serotonin reuptake inhibitor (SSRI), approved for treatment of major depressive disorder and anxiety disorders. Some SSRIs are known to prolong the QT interval; however, clinical evidence to establish a lack of association between paroxetine and corrected QT interval (QTc) prolongation is limited. Therefore, this
Sven C. van Dijkman, Mathieu Félices, Bhaskar Pandurangavittal, Sanman Ghorpade, Caroline Easterbrook, Marcin Zabielski, Oscar Della Pasqua   +6 more
wiley   +1 more source

Plasticity in the Dynamics of Myocardial Contraction [PDF]

, 1999
Richard L. Moss
openalex   +1 more source

Fiber‐type soft bioelectronics for wearable and implantable sensing and therapy

BMEMat, EarlyView.
Fiber‐type soft bioelectronics are emerging as versatile platforms for wearable and implantable health monitoring and therapeutic applications. These bioelectronics use organic and inorganic matrices combined with advanced fillers, which feature high conductivity, electrochemical sensitivity, softness, and biocompatibility.
Haneul Kim, Hak Yong Kim, Ja Hoon Koo, Gi Doo Cha, Dae‐Hyeong Kim, Hye Jin Kim   +5 more
wiley   +1 more source

Association between reduced myocardial contraction fraction and cardiovascular disease outcomes: The Multi-Ethnic Study of Atherosclerosis. [PDF]

Int J Cardiol, 2019
Abdalla M, Akwo EA, Bluemke DA, Lima JAC, Shimbo D, Maurer MS, Bertoni AG.   +6 more
europepmc   +1 more source

The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.

New England Journal of Medicine, 2000
R. Kim, E. Wu, Allen Rafael, Enn‐ling Chen, M. Parker, O. Simonetti, F. Klocke, R. Bonow, R. Judd   +8 more
semanticscholar   +1 more source

Post-Myocardial Infarction Exercise Training Reverses Cardiac Excitation-Contraction Coupling Abnormalities by Activating Cytoplasmic CaMKII [PDF]

, 2013
Alex S. Johnston, Michael Dunne, Godfrey L. Smith, Ole Johan Kemi   +3 more
openalex   +1 more source